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Abstract
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity
and mortality. While COPD diagnosis is based on lung function tests, early
stages and progression of different aspects of the disease can be visible and
quantitatively assessed on computed tomography (CT) scans. Many studies
have been published that quantify imaging biomarkers related to COPD. In
this paper we present a convolutional neural network that directly computes
visual emphysema scores and predicts the outcome of lung function tests for
195 CT scans from the COPDGene study. Contrary to previous work, the
proposed method does not encode any specific prior knowledge about what to
quantify, but it is trained end-to-end with a set of 1424 CT scans for which the
output parameters were available. The network provided state-of-the-art results
for these tasks: Visual emphysema scores are comparable to those assessed by
trained human observers; COPD diagnosis from estimated lung function reaches
an area under the ROC curve of 0.94, outperforming prior art. The method
is easily generalizable to other situations where information from whole scans
needs to be summarized in single quantities.
1 Introduction
Volumetric medical scans contain a wealth of information, spatially encoded in
a very large number of voxels, in the order of 109 for computed tomography
(CT) scans. Often clinicians are interested in single quantities that represent the
status of the patient. Ideally, CT scans would allow such measurements in an
objective and repeatable manner. From a machine learning perspective, reducing
109 measurements to a single number is a daunting task. As a consequence,
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automated systems that have been developed to carry out such tasks typically
employ a sequence of steps: data is first preprocessed, structures that are con-
sidered most relevant are segmented, within these structures certain regions are
identified where specific measurements are performed, and these measurements
are aggregated into the final quantity to be extracted. Clearly, such systems are
highly task specific and result from a large number of dedicated design decisions.
In this work we pursue an orthogonal approach and present a system, based
on a convolutional network, that is intended to generically carry out the task of
translating a volumetric scan directly into a single measurement. The system is
trained end-to-end using a set of pairs of scans (the input) and the quantity to
be derived from the scans (the output). No specific medical knowledge about
what in the scan is important to derive the desired output is encoded into the
system. We therefore refer to our system with the general name scan2num.
We apply scan2num to thoracic computed tomography (CT) scans. We
present results for various tasks related to chronic obstructive pulmonary disease
(COPD). This is currently the fourth leading cause of death worldwide, and
expected to be the third leading cause of death in 2020. In COPD patients
chronic inflammation of the airways and the lungs, usually due to smoking, leads
to structural changes in the airways and lung parenchyma. The airflow limitation
in COPD is assessed spirometrically by a combination of forced expiratory volume
in 1 second (FEV1) and the forced vital capacity (FVC). From these quantities
the GOLD score is computed, with which COPD is diagnosed and the severity
of the disease is quantified.
Where spirometry measures global functional aspects of the disease, CT
spatially resolves the pathophysiological processes and structural damage. In the
CT scans airway wall thickening can be observed, as well as emphysema resulting
from degradation of lung tissue through the enlargement and destruction of
alveoli. CT shows both the severity and extent of different emphysematous
patterns, such as centrilobular, parenchymal and paraseptal emphysema. This
information is reported by radiologists to inform treatment decisions [1]. Visual
assessment has, however, been found to have a large inter-reader variability when
reporting these quantities [2].
Ideally, analysis of CT scans would provide sensitive and repeatable mea-
surements of disease progression. From CT scans it may be possible to quantify
not only physical progression, but also the functional progression by training
models to predict functional quantities. Such appearance based measurements
could be further used for screening for COPD, for monitoring and for measuring
response to treatment. Imaging biomarkers that correlate with progression are
increasingly attracting attention, as a way to measure the effects of different
treatment options [3, 4].
To demonstrate the potential of scan2num, we apply the network in this
study to various quantitative tasks related to COPD. We trained it to predict
standardized parenchymal emphysema scores, and to assess the lung function
test scores FEV1/FVC and FEV1%predicted directly from the CT scan. These
two scores can be used to diagnose COPD and determine the GOLD stage of
the patient.
We believe that this network can also be applied to other, similar, problems
and hopefully is a step in the direction of more end-to-end optimization for CT.
2
1.1 Related Work
In this section we briefly review prior work on the tasks we address in this
study, namely emphysema quantification and deriving estimates of lung function
measurements from CT scans, and we report on related work on deriving
measurements from 3D scans using deep networks.
Emphysema quantification can be performed using a densitometric approach
or a texture based approach. In the standard densitometric analysis of emphy-
sema an emphysema score is computed as the percentage of lung tissue, excluding
airways, with a density less than a given threshold value [5]. This method has
been applied to the COPDGene dataset in [6].
As this standard method suffers from lack of reproducibility a number of
correction methodologies were introduced, such as volume correction [7] and
kernel hardness correction [8].
As an alternative to purely densitometric approaches texture based approaches
have also been introduced. The prior work in [9], [10], [11], [12], [13], [14] usually
starts by extracting local, hand crafted features from Regions of Interest(RoI).
These features are then used to train a classifier to classify the RoIs into the
previously annotated lung tissue types. Sometimes local features are also learned
based on manual RoI annotations.
Clustering avoids manual RoI annotation and is applied to emphysema
subtyping in [15], as does multiple instance learning, which is applied to the
problem of COPD classification in [16]. This approach, nevertheless, requires
hand crafted features as a basis.
Prior work in predicting lung function from CT scans also relies on hand
crafted features. These features are often quite coarse, relying on organ level
thresholds, medians and volumes as can be seen in [17].
Transitioning from hand crafted features to learned features is an important
step as the latter can often be more expressive and efficacious. Similarly not
relying on RoIs is also important as, in many cases, the functional quantities of
interest cannot be directly associated with visual patterns.
Scan-level CNN models have also recently been used for longevity prediction
from CT scans in [18]. This approach makes use of a 3D CNN model, but
therefore requires aggressive down-sampling of the scans. We instead advocate
a late fusion architecture, as this allows processing the scans at full resolution
which better enables texture based emphysema classification.
2 Materials and methods
2.1 Subjects and Image Acquisition
A major hurdle to applying large models, such as convolutional networks, to
make scan level predictions is that a large number of scan-level examples are
required to avoid overfitting. The chest CT scans used in this study were obtained
from the multi-center COPDGene Study. This study included 10,192 current or
former smokers and 108 non-smokers. Details regarding the inclusion criteria
and CT acquisition can be found in the COPDGene study design paper [19].
Briefly, subjects were scanned at full inspiration with 200 mAs. Thin-slice
reconstructions were used. Scans come from 21 centers and a wide variety of
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scanners were used. When multiple reconstruction kernels were available, we
choose the softer kernel.
We used baseline CT scans from those subjects for which both the visual
emphysema scores and lung function measurements were available. This yielded
a set of 1,788 scans, which were randomly split into a training set of 1,424 scans
a validation set of 170 scans and a test set of 195 scans, stratified according to
COPD Gold stages and outcome parameters.
2.2 Assessment of Visual Emphysema Score
The large amount of inter-reader variability in emphysema classification and
quantification has lead to efforts to precisely delineate different visual pheno-
types [1] and create reader training and scoring procedures in order to produce
consistent measures.
This was done for parenchymal emphysema, the most common type of
emphysema for COPD patients. In parenchymal emphysema small lesions form
at the center of the secondary lobule and in case of progression they coalesce
into large areas of lung destruction. The visual scoring of emphysema follows the
methodology of [20]. The severity of parenchymal emphysema was assessed by
trained medical analysts according to a six point scale of: no emphysema, trace,
mild, moderate, confluent or advanced destructive emphysema. The analysts
scored the highest grade of emphysema that is visible on the scans, even if it
was present only in one location. Weighted kappa scores for observer agreement
for this scoring system ranged from 0.70 to 0.80, indicating good to excellent
agreement. This quantity is referred to as the Visual Emphysema (VE) score.
3 Method: scan2num Network
The diagnostic process aims to find a single quantity that describes the state of
the patient. Computationally this corresponds to the conversion of a spatially
resolved image into a per-scan value. This computation is often factored into
a local computation plus a global aggregation step. Many tasks such as lesion
segmentation and nodule detection are focal, in the sense that decisions can
be made based only on a local volume, whereas other tasks are more diffuse in
nature.
While the spatial factoring of an algorithm is dictated by intrinsic attributes
of the problem in focal tasks, choosing a spatial factoring for diffuse tasks is more
difficult. This is especially true when applying CNNs which need to reconcile
the desire for gradual spatial resolution reduction with algorithm memory usage
as for training as all intermediate features of the computation need to be held in
memory in order to be able to perform back-propagation.
An extreme example of spatial factoring can be seen in emphysema score
computation, which also maps whole scans to single quantities, it makes local
single-voxel decision by thresholding and then aggregates these by averaging.
In this work we formulate a CNN network, named scan2num, that addresses
this problem for three important quantities in COPD diagnosis that describe
lung function and aspect.
The architecture that we chose is based on the computer vision task of video
classification [21], in which a number of architectures have been developed to
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Figure 1: Late fusion scan2numnetwork for whole scan classification. The net-
work follows three steps a) axial slice sampling, b) per-slice feature computation
c) feature aggregation by summation and scoring.
solve this similar problem. For our task we chose a late-fusion architecture as
these provide good classification performance. In these architectures, the same
2D network is applied to a regularly spaced subset of slices and the resulting
feature vectors are averaged to aggregate the 2D slice information over the whole
volume.
With this choice of model the process can be described as consisting of three
main steps of preprocessing, 2D per-slice feature computation and finally feature
aggregation and scoring.
In pre-processing the CT scans are cropped to the bounding box of the
lung segmentation. The lung segmentations were provided in the COPDGene
database and were computed using a previously published approach [22]. This
step removes some of the irrelevant areas from the CT scans to help the remaining
steps focus on the lung. Subsequently, regularly spaced slices are sampled from
the scan.
In the per-slice computation the aim was to extract an informative feature
vector, without letting the model become too large. This was done by a very
narrow network in order to save memory space. As identification of emphysema
depends on the local texture of the lung, slices where given to the network at
their full resolution.
In the final step the per-slice features are aggregated by mean pooling of
the per-slice feature vectors. This allows varying the number of slices that are
considered for the score. 16 slices per scan were chosen, as this was shown to
produce good results see Table 6 for details.
In the scoring step the global feature vector, representing the entire volume, is
converted into a per-scan score. A L2 regression loss was chosen as need to predict
continuous quantities, and our discrete VE scores were ranked. This method
of training has the benefit of transmuting discrete labels into continuous ones,
which may be more useful for further statistical analysis. Network architecture
and training parameters can be found in Table 1.
The network chosen is inspired by the second place entry in the Kaggle
Diabetic Retinopathy Detection Challenge and is described in Table 1.
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Table 1: Network architecture. The network processes 16 slices which are
aggregated into a single scan label.
step layer name channels filter stride output size
a) input 1 512
conv1 32 5x5 2 254
pool1 32 2x2 2 127
conv2 128 5x5 2 62
b) pool2 128 2x2 2 31
conv3 256 3x3 2 15
pool3 256 2x2 2 8
conv4 512 3x3 2 3
conv5 1024 3x3 1 1
sum 1024 1
c) fc6 1024 1
L2 loss 1 1
We trained our models using stochastic gradient descent with a batch size of
16 examples, momentum of 0.9. Linear learning rate decay was used starting with
a learning rate of 0.005 over 100k iterations. The performance on the validation
set was evaluated every 500 iterations and the network with the lowest loss on
the validation set was chosen as the final network. Weights are initialized using
the Xavier filler [23]. Weight decay of 0.0005 was used together with dropout
of 0.5 that was applied only to the fc6 layer. Data augmentation of random
mirroring and per slice rotation by ±45◦, sampled uniformly, was applied. During
training regularly spaced slices were sampled, by varying the inital slice offset
according to a uniform distribution additional data variability was achieved. All
models are trained and tested with Caffe [24] on a single NVIDIA GeForce GTX
1080.
4 Results
The described network was applied to compute predictions for three quantities
associated with COPD, the VE score, FEV1/FVC and FEV1. All results are
reported for the same test set of 195 scans. The comparison of performance
relative to other methods is hindered by the lack of a standardized test set. 1
4.1 VE Classification
We started with VE score prediction. As this is a quantity that is visually
assessed from the scan itself, it was the most likely to be predictable. The results
are shown in Figure 2b next to a plot of the percent emphysema below the
-950HU threshold as a benchmark shown in Figure 2a. In the predictions we see
a good separation of classes, except between VE scores of 0–1, which correspond
to absent and trace amounts of emphysema. This may be due to the fact that
small amount of emphysema are more easily missed by both the slice sampling
step and the feature computation step. Visual assessment of outliers is shown in
1Our test set, with individual reader scores, is available here: goo.gl/vP294U.
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Figure 4. Further visual evaluation is possible by looking at the individual VE
response per-slice. This should produce meaningful information as all feature
aggregation operations are linear. The results of this can be seen in Figure 5.
Here we see that the per slice VE score correlates with the relative presence of
emphysema.
A slight systematic offset can also be seen in the results when comparing the
linear and quadratic fits of the data. These deviation between these two shows
that the dataset is biased to prediction the dataset mean of ∼ 1.75. For further
analysis of accuracy the continuous emphysema scores were discretized. This
was done, without further calibration, by rounding to the nearest whole number.
This results in the confusion matrix Table 2.
Table 2: Confusion Matrix of VE scores comparing visually assessed and com-
puted scores.
VE Predicted
Score 0 1 2 3 4 5
A
ct
ua
l
0 44 31 1
1 10 18 2 0
2 3 16 11 2 1
3 1 17 15 6 1
4 1 3 5 1
5 1 4 1
The performance of the system can also be assessed with respect to the inter-
reader variability. The VE scores were computed from the consensus reading of
two research analysts, adjudicated by a third radiologist reading in the case of
disagreements. This was assessed by comparing the inter-analyst Spearman’s
rank correlation of ρaa = 0.84, 95% CI [0.80 - 0.88] to the first-analyst system
correlation of ρas = 0.79, 95% CI [0.74 - 0.84]. This gives P(ρaa > ρas) = .93.
The confidence intervals and probability are computed via bootstrapping with
10k samples.
VE scores were assessed based on the location in the scan with the highest
visible grade of emphysema. Even if the emphysema is very localized, this can lead
to a degree of inter-reader variability in the ground truth annotation. Given these
challenging conditions, the high level of performance at the task is impressive.
Furthermore the clinical relevance of the results should be emphasized. The
VE score has independently associated with mortality [25], indicating that this
method can provide a similarly effective mortality signal. Additionally VE scores
were associated with genetic markers linked to COPD susceptibility [20].
4.2 COPD Classification
The next task was FEV1/FVC prediction. In contrast to VE scoring, this quantity
is defined via a lung function test. It is correlated to the lung appearance as can
be seen in the correlation with the VE score as shown in Figure 2c. The results
from the automatic system can be seen in Figure 2d. From the slightly lower
correlation with visual VE scores it can be seen that it is a more difficult for the
system to predict this quantity visually.
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(a) %-emphysema correlation with VE
score ρ = 0.56, 95% CI [0.46 - 0.64]
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(b) VE score prediction. ρ = 0.84, 95% CI
[0.80 - 0.88]
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(c) FEV1/FVC correlation with VE
score. |ρ| = 0.70, 95% CI [0.63 - 0.75]
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(d) FEV1/FVC prediction ρ = 0.82, 95% CI
[0.77-0.86] showing COPD threshold.
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(e) FEV1%predicted correlation with
VE score. |ρ| = 0.47, 95% CI [0.37 - 0.56]
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(f) FEV1%predicted prediction ρ = 0.73,
95% CI [0.66 - 0.78] showing GOLD stage
thresholds.
Figure 2: Scatter plots showing the Spearman’s rank correlation of computed
predictions for various quantities (right column) compared to the correlation of
these quantities with chosen reference values (left column). The gray lines are
linear fits, all correlations shown are for the same test set of 195 patients and
have p < .001.
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FEV1/FVC is important because a patient is diagnosed with COPD if this
value is below 0.7. This discretization allows a confusion matrix, Table 3, and
accuracy metrics to be computed. Additionally a ROC curve can be computed
by using the numerical value of FEV1/FVC as a score as shown in Figure 3.
This method outperforms other CT based COPD prediction methods shown
in Table 4, even without making use of additional patient information. For
example age, body mass index, smoking status and pack-years of smoking history
are used in [26] together with the CT derived measures of air trapping, for which
an additional expiration scan is needed.
COPD Predicted
Present No Yes
No 91 10
Yes 11 83
Table 3: Confusion Matrix
of COPD diagnosis compar-
ing spirometric and com-
puted values.
Method AUC 95%CI
Mets [27] 0.83 0.81-0.86
Mets [26] Asymptomatic 0.83 0.80-0.87
Mets [26] Symptomatic 0.91 0.88-0.93
Ours 0.94 0.91-0.96
Table 4: Performance comparison of COPD
prediction methods. (Not evaluated on the same
dataset.)
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Figure 3: ROC curve for COPD classification using computed FEV1/FVC values.
4.3 GOLD Stage Prediction
The next quantity we looked at was computing FEV1%predicted. This is a
normalized form of FEV1 to account for variation in height and age. Depending
on the FEV1%predicted value patients have, they are stratified into different
GOLD stages, which measure the severity of COPD. This quantity is even less
strongly correlated with VE score, see Figure 2e, and correspondingly is harder
to predict, see Figure 2f. Again we follow the same evaluation procedure of
discretization and accuracy evaluation.
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GOLD Predicted
Stage 0 1 2 3 4
A
ct
ua
l
0 91 3 7
1 4 6 11
2 6 5 28 5
3 1 13 8 1
4 1 4 1
Table 5: Confusion Matrix of Gold
Stages.
num. slices ρ 95% CI
8 0.78 0.72 0.82
12 0.79 0.74 0.84
16 0.82 0.77 0.86
24 0.81 0.76 0.85
Table 6: Model Variation trained on
FEV1/FVC.
4.4 Model Search
One important hyper-parameter of the model is the number of slices that are
samples from the scan. In order to show how performance depends on this
parameter, we tested how well FEV1/FVC could be computed with a varying
number of slices. The result of this can be seen in Table 6.
5 Discussion
We have shown that a multi-slice analysis of full 3D CT scans, trained end-to-end,
can make meaningful predictions at the patient level. Exactly the same approach
can be used to predict multiple outputs, without the need to encode any specific
knowledge into the system about which characteristics on the scan are known
to be correlated to the output parameter that we want to predict. This is in
contrast to previously published methods to predict the severity of parenchymal
emphysema, lung function status and COPD status. These works were based on
the detection and quantification of specific local patterns in the scan, derived
from lung parenchyma and the airways. One would expect that such dedicated
methods would outperform the generic approach proposed here. The proposed
approach could function as a baseline to benchmark specific approaches. But in
fact our experimental results suggest that our system is at least equivalent or
even superior to dedicated approaches. Further evaluation on common datasets
is needed to analyze the full potential of deep convolutional methods versus
dedicated classical approaches.
There are various strategies that could be explored to maximize performance.
The most obvious suggestion is to train the systems on a larger set of CT scans.
Especially for predicting lung function status, a much larger number of CTs
with corresponding lung function tests are already contained in the COPDGene
database. In this work we limited ourselves to the scans we could obtain from the
COPDGene study for which all three output parameters we wanted to predict
were available. This allowed us to perform all experiments with the same training
set.
Another option is to add additional types of input data. Previous work
focused on predicting COPD status included additional parameters about the
patient, such as age, smoking status and history, and additional exposures are
known to correlate with COPD. Such information can be inserted at various
locations into the network to ensure that the entire system can still be trained
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Figure 4: VE score prediction outliers. The presence of upper lobe paraseptal
emphysema without parenchymal emphysema in (a)+(e) and diffuse emphysema
in (d), may have lead to over-prediction, whereas lower lobe paraseptal emphy-
sema in (c) and possible incomplete inspiration in (b)+(f) may have lead to
under-prediction.
end-to-end. Additionally, expiration CT scans could be added as an additional
input, and the system would analyze slices from multiple scans. This approach
can also be used to extend the analysis to longitudinal scan data. If data at
multiple time points would be available, prediction of clinically relevant trends,
e.g. the rate of COPD progression, can be expected to be more accurate.
Slice sampling could be improved by evaluating several samples per scan and
averaging the results. In the presented results, the system inspects only 16 slices
from a 3D scan. One could offset the location of the start slice and run the
same analysis multiple times. Furthermore, additional networks could be trained
for coronal and sagittal slices and a combination of all three could be used to
provide the final score. This would go some way to address a major drawback of
scan2num, namely that it uses a 2D approach to analyze 3D data, and only
analyzes a limited number of slices. Note that we have trained a system with
24 slices and achieved no improvement. We have also varied other aspects of
the architecture. In particular, we investigated the use a Soft-Max loss for VE
scoring, but this did not yield good results. Using L2 regression allowed the
network to perform better. One could attempt to improve performance further
in the case of tasks that produce discretized quantities by additional calibration
that may compensate for prediction bias.
A potential drawback of the overall approach, that may limit wider appli-
cability to other tasks, is the requirement of a large set of labeled scans. For
this work the COPDGene trial provided these, making it an excellent setting
to explore the performance of such architectures. We hope that these datasets
can be used as benchmarks for evaluating architecture improvements such as
those mentioned above. Better performance would allow the use of fewer scans,
enabling the application of this approach to a larger set of problems.
In this work we have predicted lung function tests results from CT scans.
Obviously performing lung function tests directly is a viable alternative. We
like to stress that in clinical practice an enormous amount of chest CT scans
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Figure 5: The plot above shows VE score contributions for each sampled axial
slices for four random scans. The maximal and minimal VE response are indicated
by triangles, those marked with letters are shown below. Slice a shows extensive
emphysema in the center of the right lung, scan b shows a small emphysema
lesion above the right fissure and slice c shows healthy slices are scored correctly.
The images are best viewed zoomed in on a large computer monitor.
are acquired in subjects who are at risk for chronic lung diseases but do not
undergo lung functions testing. This is especially true now CT lung cancer
screening programs are being implemented. CT based surrogate lung function
measurements may therefore be a good and extremely cheap way to also screen
for COPD, as suggested by Mets et al. [27]. If visual surrogates become better,
they could be used as a second measurement for lung function in order to
decrease the variance of this test. It may be possible to use similar methods
to identify which lung cancer screening participants are particularly at risk of
the disease and to adjust screening frequency or follow up accordingly. A recent
study indicated that risk for cardiovascular disease can be assessed by visually by
radiologists [28], possibly scan2numcould achieve similar results for this task.
6 Conclusion
This paper shows that learning VE, FEV1/FVC and FEV1 from whole scans is
possible, even with relatively simple networks. Whole scan end-to-end learning
is a general method which can be applied to a large number of diagnostic and
image quantification processes in radiology. We hope to have shown that the
proposed method is sufficiently attractive for it to be considered for other tasks.
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